PBS Biotech Acquires Integrity CMI

The two companies will reconfigure their assets and personnel to maximize design and engineering operations and build out their manufacturing facilities.

Single-use bioreactors developer PBS Biotech has acquired Integrity CMI which has experience in design, assembly, testing, packaging and sterilization of medical devices and biotech products.

The added technical capabilities and factory space obtained from the acquisition will augment PBS Biotech’s manufacturing capability for disposable vessels, bags, and related plastic parts assemblies of single-use bioreactors under stringent clean room environmental controls.

The two companies will reconfigure their assets and personnel to maximize design and engineering operations and build out their manufacturing facilities. The Integrity CMI facility will focus on manufacturing the PBS disposable vessels and bags.